Treatment Arm
Visit number vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 68.7 | ± 25.3 | 63.7 | 21.8 | 254.8 | 2 | 318 |
Follow-up | 275 | 67.3 | ± 28.2 | 64.4 | 14.9 | 148.0 | 26 | 301 |
Treatment Arm vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 68.7 | ± 25.3 | 63.7 | 21.8 | 254.8 | 2 | 318 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 106 | 67.4 | ± 22.4 | 64.6 | 21.8 | 116.6 | - | 106 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 105 | 67.3 | ± 22.9 | 62.2 | 31.8 | 133.8 | 1 | 106 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 105 | 71.5 | ± 30.0 | 65.7 | 31.9 | 254.8 | 1 | 106 |
Treatment Arm vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 67.3 | ± 28.2 | 64.4 | 14.9 | 148.0 | 26 | 301 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 94 | 69.2 | ± 24.2 | 65.8 | 27.9 | 145.4 | 6 | 100 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 95 | 76.5 | ± 27.7 | 72.6 | 14.9 | 141.6 | 6 | 101 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 86 | 55.1 | ± 28.5 | 48.2 | 18.6 | 148.0 | 14 | 100 |
Age category vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 68.7 | ± 25.3 | 63.7 | 21.8 | 254.8 | 2 | 318 |
45-54 years | 52 | 60.6 | ± 21.6 | 55.0 | 21.8 | 118.9 | 1 | 53 |
55-64 years | 139 | 68.5 | ± 22.2 | 64.6 | 32.1 | 133.8 | - | 139 |
65 years or older | 125 | 72.3 | ± 29.2 | 68.8 | 32.3 | 254.8 | 1 | 126 |
Age category vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 67.3 | ± 28.2 | 64.4 | 14.9 | 148.0 | 25 | 300 |
45-54 years | 42 | 62.2 | ± 23.2 | 60.1 | 18.6 | 113.1 | 7 | 49 |
55-64 years | 117 | 65.5 | ± 28.0 | 63.9 | 18.8 | 145.4 | 10 | 127 |
65 years or older | 116 | 71.0 | ± 29.6 | 65.8 | 14.9 | 148.0 | 8 | 124 |
Gender of the participant vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 68.7 | ± 25.3 | 63.7 | 21.8 | 254.8 | 2 | 318 |
Female | 84 | 62.8 | ± 20.5 | 60.2 | 31.8 | 116.2 | - | 84 |
Male | 232 | 70.8 | ± 26.6 | 66.6 | 21.8 | 254.8 | 2 | 234 |
Gender of the participant vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 67.3 | ± 28.2 | 64.4 | 14.9 | 148.0 | 26 | 301 |
Female | 73 | 62.7 | ± 27.1 | 59.7 | 18.8 | 132.8 | 6 | 79 |
Male | 202 | 69.0 | ± 28.4 | 65.7 | 14.9 | 148.0 | 20 | 222 |
Race of the participant vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 315 | 68.7 | ± 25.4 | 63.1 | 21.8 | 254.8 | 2 | 317 |
White | 255 | 72.2 | ± 25.8 | 68.8 | 31.9 | 254.8 | 1 | 256 |
American Indian or Alaskan Native | 2 | 37.0 | ± 6.9 | 37.0 | 32.1 | 41.8 | - | 2 |
Black or African American | 42 | 55.3 | ± 16.6 | 52.4 | 31.8 | 107.8 | 1 | 43 |
Asian | 6 | 63.3 | ± 20.4 | 60.5 | 34.7 | 87.8 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 73.6 | - | 73.6 | 73.6 | 73.6 | - | 1 |
Other | 4 | 41.9 | ± 13.7 | 47.3 | 21.8 | 51.3 | - | 4 |
Multiple | 5 | 43.1 | ± 11.0 | 38.1 | 34.2 | 60.1 | - | 5 |
Race of the participant vs Maximum duration of respiratory events: All respiratory events with at least 50% flow reduction and without any oxygen desat threshold used during estimate sleep duration from type III home sleep apnea test
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 274 | 67.4 | ± 28.2 | 64.4 | 14.9 | 148.0 | 25 | 299 |
White | 222 | 68.8 | ± 28.8 | 66.0 | 14.9 | 148.0 | 19 | 241 |
American Indian or Alaskan Native | 2 | 38.7 | ± 26.9 | 38.7 | 19.7 | 57.7 | - | 2 |
Black or African American | 35 | 63.1 | ± 25.2 | 56.5 | 25.8 | 129.7 | 6 | 41 |
Asian | 6 | 55.5 | ± 20.0 | 60.3 | 28.1 | 75.7 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 107.6 | - | 107.6 | 107.6 | 107.6 | - | 1 |
Other | 3 | 62.0 | ± 23.2 | 66.9 | 36.7 | 82.3 | - | 3 |
Multiple | 5 | 55.9 | ± 20.1 | 49.9 | 42.1 | 91.1 | - | 5 |